rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Chan Henry Lee

SVP, General Counsel

Company insider

Files Form 4 as: SVP, General Counsel, BeOne Medicines.

Every Form 4 they filed

In numbers

Trades disclosed
204
Buys
0
Sells
28
Bought
$0
Sold
$20.5M
Companies
1
Companies where not an officer
0
First trade
15 Jun 2023
Last trade
30 Sep 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
ONC BeOne MedicinesOfficer · Biotechnology · last 30 Sep 20260 buys · 28 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 2 Oct 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$418K1,115 at $375.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$158K812 at $194.47filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$226K1,058 at $213.32filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$127K796 at $159.03filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—10,556 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—13,754 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—10,348 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$960K2,666 at $360.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—10,556 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—13,754 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—10,348 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$158K812 at $194.47filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$226K1,058 at $213.32filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$127K796 at $159.03filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$960K2,666 at $360.00filing
30 Jul 2026filed 3 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$338K1,044 at $323.69filing
30 Jul 2026filed 3 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$338K1,044 at $323.69filing
22 Jul 2026filed 24 Jul 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$100K514 at $194.47filing
22 Jul 2026filed 24 Jul 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$142K665 at $213.32filing
22 Jul 2026filed 24 Jul 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$78K490 at $159.03filing

Sectors

Health Care28

Buys in green, sells in red, by the company’s sector.

Related people

Xiaodong WangDirector and Other role · Director and Other at BeOne Medicines, filing Form 4 there in the last year
BAKER BROS. ADVISORS LPDirector and 10% owner · Director at BeOne Medicines, filing Form 4 there in the last year
Titus B. BallPrincipal Accounting Officer · Principal Accounting Officer at BeOne Medicines, filing Form 4 there in the last year
Xiaobin WuPresident and COO · President and COO at BeOne Medicines, filing Form 4 there in the last year
John OylerChief Executive Officer · Chief Executive Officer at BeOne Medicines, filing Form 4 there in the last year
Aaron RosenbergChief Financial Officer · Also traded ONC in the last 90 days